| scholarly article | Q13442814 |
| P2093 | author name string | Henk van Faassen | |
| Wangxue Chen | |||
| J Wayne Conlan | |||
| Greg Harris | |||
| Rhonda KuoLee | |||
| Xigeng Zhao | |||
| P2860 | cites work | Statistical analysis of real-time PCR data | Q25255616 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice | Q33608616 | ||
| Innate immunity and pulmonary host defense | Q33864369 | ||
| Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology | Q34008575 | ||
| Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice | Q34131101 | ||
| Overview of nosocomial infections caused by gram-negative bacilli | Q34444001 | ||
| Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection | Q34529324 | ||
| Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection | Q34721449 | ||
| Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem | Q35132306 | ||
| Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica | Q35567211 | ||
| How do neutrophils and pathogens interact? | Q35703042 | ||
| Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice | Q35783786 | ||
| Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis | Q35910851 | ||
| Interleukin 1: an important mediator of host resistance against Pneumocystis carinii | Q36231708 | ||
| Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus | Q36238039 | ||
| Clinical impact and pathogenicity of Acinetobacter. | Q36282248 | ||
| Fibrin-mediated protection against infection-stimulated immunopathology | Q36370606 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Defensins mediate the microbicidal activity of human neutrophil granule extract against Acinetobacter calcoaceticus | Q37019549 | ||
| Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice | Q37523336 | ||
| Antimicrobial mechanisms against Acinetobacter calcoaceticus of rat polymorphonuclear leukocyte granule extract | Q40157545 | ||
| Bacterial isolates in neutropenic febrile patients | Q40752257 | ||
| Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody | Q41816592 | ||
| Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS. | Q43215876 | ||
| Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia | Q43736106 | ||
| Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis | Q44265614 | ||
| Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. | Q54021263 | ||
| Differential Roles of CD14 and Toll-like Receptors 4and 2 in MurineAcinetobacterPneumonia | Q62516238 | ||
| The Acute‐Phase Response and Serum Amyloid A Inhibit the Inflammatory Response toAcinetobacter baumanniiPneumonia | Q62516241 | ||
| An eosinophil-dependent mechanism for the antitumor effect of interleukin-4 | Q68218438 | ||
| Fulminant community-acquired Acinetobacter pneumonia in a healthy woman | Q72675302 | ||
| Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection | Q79799142 | ||
| Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome | Q79846012 | ||
| Neutrophil involvement in cross-priming CD8+ T cell responses to bacterial antigens | Q80363106 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| host resistance | Q123944447 | ||
| P304 | page(s) | 5597-5608 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice | |
| P478 | volume | 75 |
| Q37036579 | A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain |
| Q37310357 | Acinetobacter baumannii Coordinates Urea Metabolism with Metal Import To Resist Host-Mediated Metal Limitation |
| Q33971195 | Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma |
| Q37213637 | Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. |
| Q36569183 | Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes |
| Q33840920 | Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles |
| Q37202840 | Acinetobacter baumannii: an emerging multidrug-resistant threat |
| Q27015109 | Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options |
| Q38008459 | Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models |
| Q28478751 | Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection |
| Q64091015 | Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice |
| Q35154057 | Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection |
| Q92823706 | Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice |
| Q35366734 | Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration |
| Q90458207 | Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice |
| Q97525858 | Cathelicidin-related Antimicrobial Peptide Contributes to Host Immune Responses Against Pulmonary Infection with Acinetobacter baumannii in Mice |
| Q39038590 | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges |
| Q26996396 | Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity |
| Q36035894 | Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii |
| Q36256352 | Current advances and challenges in the development of Acinetobacter vaccines |
| Q34162588 | Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia |
| Q33552294 | Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response |
| Q28554305 | Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements |
| Q37241627 | Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. |
| Q34596026 | Epithelial innate immune response to Acinetobacter baumannii challenge |
| Q36277390 | Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. |
| Q35661920 | Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia |
| Q40668574 | Host resistance to intranasal Acinetobacter baumannii reinfection in mice |
| Q38013796 | Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection |
| Q92404410 | Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion |
| Q40147562 | Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii. |
| Q90176780 | IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages |
| Q36156159 | Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. |
| Q27339544 | Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration |
| Q30440550 | Imaging mass spectrometry for assessing temporal proteomics: analysis of calprotectin in Acinetobacter baumannii pulmonary infection |
| Q36555685 | Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii |
| Q33395165 | Immunomodulatory and protective roles of quorum-sensing signaling molecules N-acyl homoserine lactones during infection of mice with Aeromonas hydrophila |
| Q35650658 | In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii |
| Q36276776 | In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii |
| Q90235208 | Innate Immune Responses to Acinetobacter baumannii in the Airway |
| Q35139329 | Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance |
| Q46151080 | Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice |
| Q28743895 | Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge |
| Q28389893 | Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques |
| Q28504978 | Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection |
| Q39373932 | Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin |
| Q35802766 | Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production |
| Q37680545 | Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection |
| Q40097164 | Mouse Models of Acinetobacter baumannii Infection |
| Q44294907 | NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia |
| Q40391889 | NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice. |
| Q40160686 | NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection |
| Q91989820 | Natural history of Acinetobacter baumannii infection in mice |
| Q36167957 | Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model |
| Q37033050 | Neutrophils are essential for rapid clearance of Enterococcus faecium in mice |
| Q38805100 | New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii. |
| Q46242619 | Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs. |
| Q28389554 | Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice |
| Q57294459 | OxyR regulates the transcriptional response to hydrogen peroxide |
| Q50185124 | Pathogenic Bacterium Acinetobacter baumannii Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion |
| Q92576300 | Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection |
| Q35270290 | Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model |
| Q37099423 | Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice |
| Q34328536 | Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection |
| Q36076268 | SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice. |
| Q34298295 | Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3. |
| Q36453011 | Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection |
| Q34082984 | Staphylococcus aureus produces membrane-derived vesicles that induce host cell death |
| Q39265442 | The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections |
| Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
| Q38328275 | The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection |
| Q59125140 | The lytic transglycosylase MltB connects membrane homeostasis and in vivo fitness of Acinetobacter baumannii |
| Q36053482 | Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection. |
| Q94545399 | Transcriptome Profiling of Lung Innate Immune Responses Potentially Associated With the Pathogenesis of Acinetobacter baumannii Acute Lethal Pneumonia |
| Q46237978 | Uncovering the mechanisms of Acinetobacter baumannii virulence |
| Q90312140 | Underscoring interstrain variability and the impact of growth conditions on associated antimicrobial susceptibilities in preclinical testing of novel antimicrobial drugs |
| Q33637895 | Vaccines for Acinetobacter baumannii: thinking "out of the box". |
| Q37669333 | When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system |
| Q37202830 | Why are we afraid of Acinetobacter baumannii? |
Search more.